跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Methylprednisolone Sodium Succinate for Injection
Approved
化学药品
Methylprednisolone Sodium Succinate for Injection
Pfizer SA
🇨🇳 National Medical Products Administration
Approval Date
Aug 18, 2020
Approval ID
888kzPhKSrd
Company
Pfizer SA
Type
化学药品
Approval Details
Approval Id
888kzPhKSrd
Approval Number
国药准字HJ20170197
Generic Name
注射用甲泼尼龙琥珀酸钠
Generic Name En
Methylprednisolone Sodium Succinate for Injection
Trade Name
甲强龙
Brand Name
甲强龙
Drug Type
化学药品
Dosage Form
注射剂
Strength
40mg
Reg Date
2020-08-18
Expired Date
2025-08-17
Company Name
Pfizer SA
Company Address
Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
Production Company Name
Pfizer Manufacturing Belgium
Production Company Address
Rijksweg 12, 2870 Puurs, Belgium
Company Detail Path
/organization/pfizer-sa
Production Company Detail Path
/organization/pfizer-manufacturing-belgium
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 18, 2020
Approval ID
888kzPhKSrd
Type
化学药品
Back to NMPA Approvals
甲强龙 - NMPA Drug Approval Details
